Tumour necrosis factor-α inhibitors/immunosuppressants: Cancer: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1423, 2012-01 ,pp. : 48-48

Adis International

Access to resources Recommend Favorite

Tumour Necrosis Factor-α Polymorphisms and Hepatocellular Carcinoma: a Meta-analysis

By Qin H   Liu B   Shi T   Liu Y   Sun Y   Ma Y  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 760-768

Field House Publishing

Access to resources Recommend Favorite

Exploring the Cardio-metabolic Relevance of T-cadherin: A Pleiotropic Adiponectin Receptor

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 3, 2017-10 ,pp. : 200-206

Bentham Science Publishers

Access to resources Recommend Favorite

Tumour Necrosis Factor-α Antagonists in the Management of Rheumatoid Arthritis in the Elderly: A Review of Their Efficacy and Safety

By Radovits Beáta J.   Kievit Wietske   Laan Roland F.J.M.  

Drugs & Aging, Vol. 26, Iss. 8, 2009-08 ,pp. : 647-664

Adis International

Access to resources Recommend Favorite

Tumour necrosis factor-α inhibitors have a growing role in managing late-onset ankylosing spondylitis and spondylarthritis

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 2, 2011-02 ,pp. : 13-16

Adis International

Access to resources Recommend Favorite